Stryker Corp. (NYSE: SYK ) made an offer to buy Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, in an all-cash deal worth $316 million.
Orthovita Inc.
Allergan profits slimmer despite plumper sales | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Covidien completes enrollment on ev3 atherectomy device study | Research roundup
Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year.
BioMimetic losses widen 60 percent | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
FDA gives Stryker’s hip replacement the OK | Regulatory roundup
Stryker Corp. (NYSE:SYK) received 510(k) clearance from the Food & Drug Administration for its new hip replacement system.
The clearance adds another product to the Kalamazoo, Mich.-based-medical device maker’s portfolio of orthopedic devices, which performed well through the recession.